TITLE

The effects of resistance training on ApoB/ApoA-I ratio, Lp(a) and inflammatory markers in patients with type 2 diabetes

AUTHOR(S)
Kadoglou, Nikolaos; Fotiadis, Grigorios; Athanasiadou, Zoi; Vitta, Ioulia; Lampropoulos, Stylianos; Vrabas, Ioannis
PUB. DATE
December 2012
SOURCE
Endocrine (1355008X);Dec2012, Vol. 42 Issue 3, p561
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The purpose of this study was to investigate the effects of resistance training (RT) on novel cardiovascular risk factors in patients with type 2 diabetes mellitus (T2DM). We enrolled 52 overweight/obese, type 2 diabetic patients, with inadequate glycemic control (HbA1c > 6.5 %), but without overt diabetic vascular complications. Participants were randomly assigned into two equivalent groups ( n = 26): (1) Resistance exercise group: subjects underwent a supervised RT program (3-times/week, 60 min/session, 2-3 sets of 8 machine-weight exercises, 60-80 % of one-repetition maximum). (2) Control group (CG): at study entrance, they received a structured exercise counseling to increase daily physical activity. Clinical parameters, cardiorespiratory capacity, glycemic and lipid profile, apolipoprotein A-I (ApoA-I), apolipoprotein B (ApoB), Lipoprotein(a) [Lp(a)], insulin resistance (HOMA-IR), high-sensitivity CRP (hsCRP), fibrinogen were measured before and after 3 months. RT significantly reduced glycemic indexes, insulin resistance and systolic blood pressure, compared to CG ( p < 0.05). Moreover, exercise-treated patients conferred a remarkable downregulation in ApoB levels (from 135.92 ± 30.97 mg/dL to 85.9 ± 26.46 mg/dL, p < 0.001) as compared to CG (from 126.33 ± 36.59 mg/dL to 116.23 ± 27.52 mg/dL, p = 0.872) ( p < 0.001). Similarly, ApoB/ApoA-I ratio was considerably decreased in REG rather than CG (-0.32 ± 0.09 vs 0.02 ± 0.01, p < 0.001). Notably, ApoA-I, Lp(a), hsCRP, fibrinogen, the rest of lipid parameters, body weight and exercise capacity remained unaltered in both groups ( p > 0.05). Among variables, HOMA-IR reduction was found to be an independent predictor of changes in ApoB/ApoA-I ratio ( R = 0.406, p = 0.041) in REG. Long-term RT ameliorated glycemic control, insulin sensitivity and ApoB/ApoA-I ratio in individuals with T2DM. Although we did not observe significant benefits in the rest of cardiovascular risk factors, our results indicate a merely beneficial impact of RT.
ACCESSION #
83709739

 

Related Articles

  • Elevated A1C is associated with impaired early-phase insulin secretion rather than insulin resistance in Koreans at high risk for developing diabetes. Kim, Tae; Park, Man; Lee, Seong; Yang, Sae; Lee, Kwan; Nam, Moon; Park, Yong; Woo, Jeong; Kim, Young; Baik, Sei // Endocrine (1355008X);Dec2012, Vol. 42 Issue 3, p584 

    The purpose of this study is to examine the association of A1C with beta-cell dysfunction, insulin resistance, and cardiovascular risk factors in Koreans with the relatively high risk for the future development of diabetes. This cross-sectional study recruited subjects from the pre-diabetic...

  • Sympathovagal Imbalance Contributes to Prehypertension Status and Cardiovascular Risks Attributed by Insulin Resistance, Inflammation, Dyslipidemia and Oxidative Stress in First Degree Relatives of Type 2 Diabetics. Pal, Gopal Krushna; Adithan, Chandrasekaran; Ananthanarayanan, Palghat Hariharan; Pal, Pravati; Nanda, Nivedita; Durgadevi, Thiyagarajan; Lalitha, Venugopal; Syamsunder, Avupati Naga; Dutta, Tarun Kumar // PLoS ONE;Nov2013, Vol. 8 Issue 11, p1 

    Background: Though cardiovascular (CV) risks are reported in first-degree relatives (FDR) of type 2 diabetics, the pathophysiological mechanisms contributing to these risks are not known. We investigated the association of sympathovagal imbalance (SVI) with CV risks in these subjects. Subjects...

  • METABOLIC SYNDROME IN RHEUMATOID ARTHRITIS. Manka, V.; Galajda, P.; Sagova, I.; Klimentova, A.; Kantarova, D.; Stancik, M.; Mokan, M. // Acta Medica Martiniana;Nov2012, Vol. 12 Issue 3, p19 

    Inflammation is a key component of obesity and type 2 diabetes mellitus also as risk factors of cardiovascular disease. Patients with chronic inflammatory diseases such as rheumatoid arthritis or systemic lupus erythematosus have an increased risk of cardiovascular diseases. The expected higher...

  • C-Peptide: A New Mediator of Atherosclerosis in Diabetes. Vasic, Dusica; Walcher, Daniel // Mediators of Inflammation;2012, Vol. 2012, p1 

    Diabetes type 2 and insulin resistance are the risk factors for cardiovascular disease. It is already known that atherosclerosis is an inflammatory disease, and a lot of different factors are involved in its onset. C-peptide is a cleavage product of proinsulin, an active substance with a number...

  • COMPLICATIONS--MACROVASCULAR--ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND HUMAN DIABETES.  // Diabetes;Jun 2014 Supplement, pA566 

    The article presents abstracts of studies related to diabetes and atherosclerotic cardiovascular disease, which include an evaluation of cardiovascular risk (CVR) based on the existence of non-alcoholic fatty liver disease (NAFLD) and albuminaria in patients with type 2 diabetes, and the...

  • The Obesity Epidemic: It's a Guy Thing. GOLDMAN, ERIK // Holistic Primary Care;Winter2013, Vol. 14 Issue 4, p1 

    The article focuses on the obesity epidemic in men. It discusses the three interrelated factors to mortality and morbidity in men, as identified by Doctor John La Puma, such as declining testosterone, increasing visceral fat and chronic inflammation. Several tips are offered to help men take...

  • Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement. Siu, Albert L.; U.S. Preventive Services Task Force // Annals of Internal Medicine;12/1/2015, Vol. 163 Issue 11, p861 

    Description: Update of the 2008 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for diabetes in asymptomatic adults.Methods: The USPSTF reviewed the evidence on screening for impaired fasting glucose, impaired glucose tolerance, and type 2...

  • The ENPP1 Q121 Variant Predicts Major Cardiovascular Events in High-Risk Individuals. Bacci, Simonetta; Rizza, Stefano; Prudente, Sabrina; Spoto, Belinda; Powers, Christine; Facciorusso, Antonio; Pacilli, Antonio; Lauro, Davide; Testa, Alessandra; Yuan-Yuan Zhang; Di Stolfo, Giuseppe; Mallamaci, Francesca; Tripepi, Giovanni; Rui Xu; Mangiacotti, Davide; Aucella, Filippo; Lauro, Renato; Gervino, Ernest V.; Hauser, Thomas H.; Copetti, Massimiliano // Diabetes;Mar2011, Vol. 60 Issue 3, p1000 

    OBJECTIVE--Insulin resistance (IR) and cardiovascular disease may share a common genetic background. We investigated the role of IR-associated ENPP1 K121Q polymorphism (rs1044498) on cardiovascular disease in high-risk individuals. RESEARCH DESIGN AND METHODS--A prospective study (average...

  • Inflammation, Adiponectin, Obesity and Cardiovascular Risk. Mangge, H.; Almer, G.; Truschnig-Wilders, M.; Schmidt, A.; Gasser, R.; Fuchs, D. // Current Medicinal Chemistry;Dec2010, Vol. 17 Issue 36, p4511 

    No abstract available.

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics